Recent studies have shown that dysregulation of TACC1 seems to be associated with the occurrence of multiple malignancies, such as rhabdomyosarcoma, breast cancer, gastric cancer, leukaemia and ovarian cancer [3, 9–13]. The gene discussed is TACC1; the disease is breast carcinoma.